Home
Research
About
Services
Contact
Partners
Sign up
Blog
More
All Posts
Search
Brian White
3 days ago
Diurnal Business Update
Brian White
6 days ago
Preliminary 2020 revenue and portfolio progress
Andrew Keith
Dec 21, 2020
Basilea's derazantinib - a differentiated FGFR inhibitor
Andrew Keith
Dec 7, 2020
Diurnal Group and Spruce Biosciences
Andrew Keith
Nov 13, 2020
Diurnal Group - Positive initial signs in the US for Alkindi
Andrew Keith
Nov 11, 2020
Diurnal Group - Unveiling DITEST
Andrew Keith
Oct 19, 2020
Introducing Basilea Pharmaceutica
Andrew Keith
Oct 9, 2020
Diurnal Group - Spruce Biosciences
